These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16954111)

  • 1. The effect of poloxamer viscosity on liquid-filling of solid dispersions in hard gelatin capsules.
    Kattige A; Rowley G
    Drug Dev Ind Pharm; 2006 Sep; 32(8):981-90. PubMed ID: 16954111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of rheological behaviour of particulate/polymer dispersions on liquid-filling characteristics for hard gelatin capsules.
    Kattige A; Rowley G
    Int J Pharm; 2006 Jun; 316(1-2):74-85. PubMed ID: 16567071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheology and filling characteristics of particulate dispersions in polymer melt formulations for liquid fill hard gelatin capsules.
    Rowley G; Hawley AR; Dobson CL; Chatham S
    Drug Dev Ind Pharm; 1998 Jul; 24(7):605-11. PubMed ID: 9876504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Rheology and Poloxamers Properties on Release of Drugs from Silicon Dioxide Gel-Filled Hard Gelatin Capsules-A Further Enhancement of Viability of Liquid Semisolid Matrix Technology.
    Sultana M; Butt MA; Saeed T; Mahmood R; Ul Hassan S; Hussain K; Raza SA; Ahsan M; Bukhari NI
    AAPS PharmSciTech; 2017 Aug; 18(6):1998-2010. PubMed ID: 27933585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The filling of molten and thixotropic formulations into hard gelatin capsules.
    Walker SE; Ganley JA; Bedford K; Eaves T
    J Pharm Pharmacol; 1980 Jun; 32(6):389-93. PubMed ID: 6106669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Mefenamic Acid Release from Poloxamer-Silicon Dioxide Gel Filled in Hard Gelatin Capsules - An Application of Liquid Semisolid Matrix Technology for Insoluble Drug.
    Sultana M; Sultana S; Hussain K; Saeed T; Butt MA; Raza SA; Mahmood R; Hassan S; Anwer UU; Bukhari NI
    Curr Drug Deliv; 2022; 19(7):801-811. PubMed ID: 34477519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
    Karataş A; Bekmezci S
    Acta Pol Pharm; 2013; 70(5):883-97. PubMed ID: 24147368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K; Sistla R; Shastri NR
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suitability of phosphatidylcholine-based formulations for liquid filling in hard capsules.
    Grüne L; Bunjes H
    Eur J Pharm Sci; 2020 Oct; 153():105470. PubMed ID: 32682932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
    Gohil UC; Podczeck F; Turnbull N
    Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5.
    Jannin V; Pochard E; Chambin O
    Int J Pharm; 2006 Feb; 309(1-2):6-15. PubMed ID: 16376034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of drug and diluent particle size on the in vitro release of drug from hard gelatin capsules.
    Newton JM; Bader F
    J Pharm Pharmacol; 1980 Mar; 32(3):167-71. PubMed ID: 6103930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a melt agglomeration process on agglomerates containing solid dispersions.
    Vilhelmsen T; Eliasen H; Schaefer T
    Int J Pharm; 2005 Oct; 303(1-2):132-42. PubMed ID: 16139973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
    Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
    Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity.
    Ciper M; Bodmeier R
    Eur J Pharm Biopharm; 2006 Feb; 62(2):178-84. PubMed ID: 16260126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ lyophilisation of nifedipine directly in hard gelatine capsules.
    Crum M; Elkordy AA; Zarara M; Elkordy EA
    Pharm Dev Technol; 2013; 18(6):1379-90. PubMed ID: 22992055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moisture diffusion and permeability characteristics of hydroxypropylmethylcellulose and hard gelatin capsules.
    Barham AS; Tewes F; Healy AM
    Int J Pharm; 2015 Jan; 478(2):796-803. PubMed ID: 25526672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of additives on the presentation of a drug in hard gelatin capsules.
    Newton JM; Razzo FN
    J Pharm Pharmacol; 1977 May; 29(5):294-7. PubMed ID: 17694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semisolid matrix filled capsules: an approach to improve dissolution stability of phenytoin sodium formulation.
    El Massik MA; Abdallah OY; Galal S; Daabis NA
    Drug Dev Ind Pharm; 2003 May; 29(5):531-43. PubMed ID: 12779283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.